Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chip array data for Suit2-007 cells treated by riproximin (Rpx)

ABSTRACT: We report the effect of Rpx on human PDAC Suit2-007 cells after 48h time point

ORGANISM(S): Homo sapiens

PROVIDER: GSE152304 | GEO | 2020/09/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

Project description:We report the gene expression profile of human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

2020-09-01 | GSE152305 | GEO

Chip array data for Suit2-007 cells treated by riproximin (Rpx)

Project description:Chip array data for Suit2-007 cells treated by riproximin (Rpx)

| PRJNA638931 | ENA

Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

Project description:Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

| PRJNA638930 | ENA

RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines

Project description:RNA sequencing technology has been carried out in order to compare mRNA expression changes in epithelial BxPC-3 versus mesenchymal S2-007 cells.

2018-04-18 | GSE113259 | GEO

The nitrone compound OKN-007 delays motor neuron loss and disease progression in the G93A mouse model of Amyotrophic Lateral Sclerosis

Project description:Our study investigated the therapeutic potential of OKN-007 in the SOD1 G93A mouse model of amyotrophic lateral sclerosis (ALS). The impact of OKN-007, known for its antioxidant, anti-inflammatory, and neuroprotective properties, was tested at two doses (150 mg/kg and 300 mg/kg) at onset and late-stage disease. Results demonstrated a significant delay in disease progression at both doses, with treated mice showing a slower advance to severe disease stages compared to untreated controls. Transcriptomic analysis using bulk RNA sequencing identified dysregulated genes in G93A mice that were restored by OKN-007 treatment and pathways that showed altered expression in response to OKN-007. Overall, our findings suggest that OKN-007 holds potential as a disease-modifying treatment for ALS, although further research is needed to optimize dosing regimens and understand its long-term effects.

2024-11-10 | GSE281064 | GEO

Rhizobium sp. 007

Project description:Rhizobium sp. 007 Genome sequencing

| PRJNA674303 | ENA

Acidimicrobiales bacterium JGI 007

Project description:Acidimicrobiales bacterium JGI 007 Genome sequencing

| PRJNA372974 | ENA

Elizabethkingia anophelis FMS-007

Project description:Elizabethkingia anophelis FMS-007 Genome sequencing

| PRJNA210135 | ENA

Pisolithus tinctorius strain:Pt 007

Project description:Pisolithus tinctorius Pt 007 Resequencing